Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
2024/06/27
Employee Activity | Discover the Charm of Intangible Cultural Heritage, Enjoy the Fun of Bamboo Weaving, and Together "Craft" Beautiful Fans!
"Everyone Talks Safety, Everyone Knows How to Respond—Keeping Life Paths Clear" | Wanbangde Pharmaceutical Group Holds 2024 "Safety Production Month" Kickoff Meeting
2024/06/03
[Literature Review] Huperzine A Improves Neurological Deficits After Spontaneous Subarachnoid Hemorrhage by Inhibiting Endothelial Cell Pyroptosis
Tech Month | Step into Wanbangde Pharmaceutical, get up close with scientific research, and embark together on a journey of pharmaceutical exploration.
Warmest congratulations! | Wanbangde Pharmaceutical Group’s Academician Workstation has been officially awarded the title of "Provincial-Level Key Academician Workstation"—the official plaque ceremony has taken place!
Good News | Wanbangde Pharmaceutical Group’s Huperzine A Granted Orphan Drug Designation by the U.S. FDA for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy!
News | The Postdoctoral Research Station of Wanbangde Pharmaceutical Group Successfully Hosts the Departure and Mid-term Evaluation Meeting for Its Postdocs
Tech Month | Wanbangde Pharmaceutical Group Steadily Advances Multiple Specialized Training Sessions and Expert Exchange Activities
2024/05/17
News | CAS Experts Visit Wanbangde Pharmaceutical for Discussions and Exchange to Drive Product Enhancements
Good News | The 2024 China Brand Value Evaluation Report reveals that Wanbangde Pharmaceutical Group’s brand value has reached a new all-time high!
Tech Month | The Inaugural "Tech Month" Event Launch Conference of Wanbangde Pharmaceutical Group Successfully Held
Warmest congratulations to Wanbangde Pharmaceutical Group on receiving the U.S. FDA’s “Rare Pediatric Disease” designation for Huperzine A!
2024/05/06
Unbeatable in every match, victorious in every game—Wanbangde Pharmaceutical Group Employees' Table Tennis Tournament Concludes in Spectacular Fashion!
2024/04/13
Warmest congratulations! | Wanbangde Pharmaceutical Group's Biphenyl Dimethyl Ester API has successfully passed the on-site inspection by South Korea's MFDS!
2024/04/03
2023
